Jubilee Metals Group PLC (LON:JLP) said it entered into long-term PGM (platinum group metals) feed supply agreement with a chrome mining customer, signalling Jubilee’s PGM expansion into the Eastern Limb of the Bushveld Complex in South Africa.
Faron Pharmaceuticals Oy (LON:FARN, First North:FARON) said research has been published supporting the immunotherapeutic blockade of Clever-1 to activate anti-tumour immune responses in advanced cancer patients.
Redx Pharma PLC (AIM:REDX) said its second wholly-owned molecule has now entered the clinic. Candidate RXC007, which is being developed to treat fibrosis, will be administered to healthy volunteers to assess its safety and tolerability and also the way it interacts with the body.
Argo Blockchain PLC (LON:ARB) has unveiled an investment in a company specialising in decentralised finance (DeFi) as it updated investors on the status of its mining activities and infrastructure. In an operational update for May, the cryptocurrency miner said it has invested £146,000 in WonderFi Technologies Inc, a firm focused on bringing DeFi technology to the masses, as part of a wider C$16.4mln (£9.6mln) fundraising. As part of the investment, Argo’s chief executive will also be appointed as an unpaid advisor to WonderFi.
Advanced Oncotherapy PLC (LON:AVO) announced it has signed a letter of intent with Saba Partners for the proposed purchase of a three-treatment room LIGHT system for a total contract value of up to US$107mln (£75.5mln).
Amryt Pharma PLC (NASDAQ:AMYT; AIM:AMYT) has been granted a priority review of its new drug application for Oleogel-S10 by the US drugs watchdog with a decision expected on or before November 30. The US Food & Drug Administration fast-track has shortened the regulatory timeline from 10 months to six.
DiscoverIE Group PLC (LON:DSCV) said the current financial year has started well with a record order book.
Imperial X PLC (LON:CDL), which describes itself as a natural resource project generator, has floated on the London Stock Exchange’s Main Market today after raising £3mln through its initial public offering of shares at 3p a pop.
Kavango Resources PLC (LON:KAV) said extensive copper/silver targets have been identified on two prospecting licences at the LVR joint venture project in the Kalahari Copper Belt. The licences – 082/2018 and 083/2018 – are jointly held with LVR GeoExplorers Ltd.
Pembridge Resources PLC (LON:PERE) said it issued US$3mln (£2.1mln) of convertible loan notes, exceeding its initial target of US$2mln after the offer was oversubscribed, to fund potential future investment opportunities.